Trial reportAnnals of family medicine
Intervention to enhance communication about newly prescribed medications.
Trial report in Annals of family medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Training physicians in providing complex information to patients with multiple sclerosis: a randomised controlled trial.BMJ open · 2022Trial
- Article
- Post-Visit Patient Understanding About Newly Prescribed Medications.Journal of general internal medicine · 2021Article
- Aspects of Medication and Patient participation-an Easy guideLine (AMPEL). A conversation guide increases patients' and physicians' satisfaction with prescription talks.Naunyn-Schmiedeberg's archives of pharmacology · 2021Article
- Development and Initial Validation of the Communication About Medication by Providers-Parent Scale (CAMP-P).Global pediatric health · 2019Article
- Assessment of the steps taken towards avoidance of medication errors among hypertensive outpatients attending a tertiary health care facility in Nigeria: a cross-sectional study.The Pan African medical journal · 2019Article
- Efficiency, Efficacy, and Power in the Implementation of a Medication Adherence Aid.Health literacy research and practice · 2018Article
- Current and future perspectives on the management of polypharmacy.BMC family practice · 2017Article
- Integrating Quantitative and Qualitative Results in Health Science Mixed Methods Research Through Joint Displays.Annals of family medicine · 2015Article
- Improving Patient Outcomes: Effectively Training Healthcare Staff in Psychological Practice Skills: A Mixed Systematic Literature Review.Europe's journal of psychology · 2015Review
- Refining the Practice of Prescribing: Teaching Physician Learners How to Talk to Patients About a New Prescription.Journal of graduate medical education · 2014Article
- Infrequent older adult-primary care provider discussion and documentation of dietary supplements.Journal of the American Geriatrics Society · 2014Article
- Physician-patient communication about dietary supplements.Patient education and counseling · 2013Article
- In this issue: how we think and feel influences patient care.Annals of family medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposePhysicians prescribing new medications often do not convey important medication-related information. This study tests an intervention to improve physician-patient communication about newly prescribed medications.
methodsWe conducted a controlled clinical trial of patients in 3 primary care practices, combining data from patient surveys with audio-recorded physician-patient interactions. The intervention consisted of a 1-hour physician-targeted interactive educational session encouraging communication about 5 basic elements regarding a new prescription and a patient information handout listing the 5 basic elements. Main outcome measures were the Medication Communication Index (MCI), a 5-point index assessed by qualitative analysis of audio-recorded interactions (giving points for discussion of medication name, purpose, directions for use, duration of use, and side effects), and patient ratings of physician communication about new prescriptions.
resultsTwenty-seven physicians prescribed 113 new medications to 82 of 256 patients. The mean MCI for medications prescribed by physicians in the intervention group was 3.95 (SD = 1.02), significantly higher than that for medications prescribed by control group physicians (2.86, SD = 1.23, P <.001). This effect held regardless of medication type (chronic vs nonchronic medication). Counseling about 3 of the 5 MCI components was significantly higher for medications prescribed by physicians in the intervention group, as were patients' ratings of new medication information transfer (P = .02). Independent of intervention or control groups, higher MCI scores were associated with better patient ratings about information about new prescriptions (P = .003).
conclusionsA physician-targeted educational session improved the content of and enhanced patient ratings of physician communication about new medication prescriptions. Further work is required to assess whether improved communication stimulated by the intervention translates into better clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.